Lepu Biopharma Co., Ltd. (HKG:2157)
Hong Kong · Delayed Price · Currency is HKD 3.810
+0.110 (2.97%)
Jun 18, 2026, 4:08 PM HKT
Lepu Biopharma Market Cap
Lepu Biopharma has a market cap or net worth of 6.68 billion as of June 17, 2026. Its market cap has decreased by -12.88% in one year.
Market Cap
6.68B
Enterprise Value
6.77B
Revenue
1.04B
Ranking
n/a
PE Ratio
22.33
Stock Price
3.81
Market Cap Chart
Since February 23, 2022, Lepu Biopharma's market cap has decreased from 11.84B to 6.68B, a decrease of -43.62%. That is a compound annual growth rate of -12.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 6.68B | -25.55% |
| Dec 31, 2025 | 8.97B | 100.10% |
| Dec 31, 2024 | 4.48B | -35.85% |
| Dec 29, 2023 | 6.99B | -42.72% |
| Dec 30, 2022 | 12.20B | 3.00% |
| Feb 23, 2022 | 11.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ascletis Pharma | 9.93B |
| Everest Medicines | 9.74B |
| CARsgen Therapeutics Holdings | 8.93B |
| HBM Holdings | 8.70B |
| Suzhou Ribo Life Science | 8.56B |
| CStone Pharmaceuticals | 7.72B |
| Shanghai Haohai Biological Technology | 7.53B |
| Alphamab Oncology | 6.79B |